Related Experiment Video
Updated: May 17, 2026
06:45
Integrated Photoacoustic, Ultrasound, and Angiographic Tomography (PAUSAT) for NonInvasive Whole-Brain Imaging of Ischemic Stroke
Published on: June 2, 2023
Transcranial sonography in Parkinson's disease
Edson Bor-Seng-Shu1, José Luiz Pedroso, Daniel Ciampi de Andrade
1Division of Clinical Neurosurgery, Universidade de São Paulo, São Paulo, SP, Brazil.
Einstein (Sao Paulo, Brazil)
|October 12, 2012
Summary
Transcranial sonography reveals substantia nigra hyperechogenicity in over 90% of idiopathic Parkinson's disease cases. This non-invasive technique aids in diagnosing parkinsonian syndromes by identifying nigrostriatal pathway dysfunction.
Area of Science:
- Neuroimaging
- Neurology
- Medical Diagnostics
Background:
- Transcranial sonography (TCS) is a valuable, non-invasive, and low-cost diagnostic tool.
- Parkinsonian syndromes require accurate differential diagnosis.
- Substantia nigra (SN) abnormalities are implicated in Parkinson's disease (PD).
Purpose of the Study:
- To evaluate the utility of TCS in the differential diagnosis of parkinsonian syndromes.
- To investigate the prevalence and significance of SN hyperechogenicity in idiopathic PD.
Main Methods:
- Utilized transcranial sonography to assess the mesencephalic substantia nigra region.
- Focused on identifying echogenicity patterns in patients with parkinsonian syndromes, particularly idiopathic PD.
Main Results:
- Increased echogenicity (hyperechogenicity) of the substantia nigra was observed in over 90% of idiopathic Parkinson's disease patients.
- This finding is indicative of dopaminergic nigrostriatal pathway dysfunction.
Conclusions:
- Substantia nigra hyperechogenicity detected by TCS is a key indicator in the differential diagnosis of parkinsonian syndromes.
- TCS offers a practical method for identifying nigrostriatal pathway dysfunction in PD.
- The technique facilitates distinguishing idiopathic PD from other parkinsonian syndromes.
